ECOG PCO-RL: E4508: Three-Arm Randomized Phase II Study of Carboplatin and Paclitaxel in Combination with Cetuximab, IMC-A12 or Both for Advanced Non-small Cell Lung Cancer Patients Who Will Not Receive Bevacizumab-based Therapy

Project: Research project

Project Details

StatusFinished
Effective start/end date6/1/09 → 5/31/11

Funding

  • Frontier Science and Technology Research Foundation (PCOE4508R-00 // CA021115)
  • National Cancer Institute (PCOE4508R-00 // CA021115)